CRSP
Price
$46.70
Change
-$0.08 (-0.17%)
Updated
Jun 26 closing price
Capitalization
4.03B
45 days until earnings call
NKTR
Price
$29.68
Change
+$0.56 (+1.92%)
Updated
Jun 26 closing price
Capitalization
368.24M
41 days until earnings call
Interact to see
Advertisement

CRSP vs NKTR

Header iconCRSP vs NKTR Comparison
Open Charts CRSP vs NKTRBanner chart's image
CRISPR Therapeutics AG
Price$46.70
Change-$0.08 (-0.17%)
Volume$2.68M
Capitalization4.03B
Nektar Therapeutics
Price$29.68
Change+$0.56 (+1.92%)
Volume$7.04M
Capitalization368.24M
CRSP vs NKTR Comparison Chart in %
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. NKTR commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and NKTR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CRSP: $46.70 vs. NKTR: $29.68)
Brand notoriety: CRSP: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 121% vs. NKTR: 397%
Market capitalization -- CRSP: $4.03B vs. NKTR: $368.24M
CRSP [@Biotechnology] is valued at $4.03B. NKTR’s [@Biotechnology] market capitalization is $368.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRSP and NKTR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 6 TA indicator(s) are bullish while NKTR’s TA Score has 6 bullish TA indicator(s).

  • CRSP’s TA Score: 6 bullish, 4 bearish.
  • NKTR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CRSP and NKTR are a good buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а +5.11% price change this week, while NKTR (@Biotechnology) price change was +244.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.03B) has a higher market cap than NKTR($368M). NKTR YTD gains are higher at: 112.760 vs. CRSP (18.648). NKTR has higher annual earnings (EBITDA): -97.97M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. NKTR (219M). NKTR has less debt than CRSP: NKTR (100M) vs CRSP (219M). NKTR has higher revenues than CRSP: NKTR (87.2M) vs CRSP (35M).
CRSPNKTRCRSP / NKTR
Capitalization4.03B368M1,096%
EBITDA-455.24M-97.97M465%
Gain YTD18.648112.76017%
P/E RatioN/AN/A-
Revenue35M87.2M40%
Total Cash1.86B219M847%
Total Debt219M100M219%
FUNDAMENTALS RATINGS
CRSP vs NKTR: Fundamental Ratings
CRSP
NKTR
OUTLOOK RATING
1..100
2296
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
4034
P/E GROWTH RATING
1..100
7984
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (67) in the Biotechnology industry is in the same range as NKTR (82). This means that CRSP’s stock grew similarly to NKTR’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NKTR (100). This means that CRSP’s stock grew similarly to NKTR’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as NKTR (99). This means that CRSP’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's Price Growth Rating (34) in the Biotechnology industry is in the same range as CRSP (40). This means that NKTR’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's P/E Growth Rating (79) in the Biotechnology industry is in the same range as NKTR (84). This means that CRSP’s stock grew similarly to NKTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPNKTR
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYPX33.340.33
+1.00%
American Beacon Man Lg Cp Growth Inv
IEGAX23.45N/A
N/A
Invesco EQV Intl Small Company A
FSMVX28.87N/A
N/A
Fidelity Mid Cap Value
LGLOX52.87N/A
N/A
Lord Abbett Growth Leaders F3
FNDMX13.08N/A
N/A
Fidelity Series Sust Non-US Dev Mrkt Fd

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRSP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+1.92%
CRSP - NKTR
46%
Loosely correlated
-0.17%
IPSC - NKTR
45%
Loosely correlated
+0.23%
IMNM - NKTR
44%
Loosely correlated
+1.27%
CRNX - NKTR
44%
Loosely correlated
-1.38%
RXRX - NKTR
44%
Loosely correlated
+4.65%
More